Top Markets
Coin of the day
Lumosa Therapeutics Co., Ltd. Lumosa Therapeutics Co., Ltd.

Lumosa Therapeutics Co., Ltd.

6535
Kedudukan dalam Saham #14754
Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company,... Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company, headquartered in Taiwan, focused on developing innovative therapies for neurological and oncological diseases. Its most advanced product, LT-1001, an injectable analgesic, has completed Phase III clinical trials for the management of severe post-operative pain. The company's pipeline also includes LT3001, currently in Phase II for treating acute ischemic stroke; LT5001, which has finished Phase Ib trials for uremic pruritus; and LT2003, an oncology drug candidate in its preclinical development stage. Founded in 2000, Lumosa Therapeutics maintains its operational base in Taipei.
Harga Saham
$2.35
Modal Pasaran
$394.12M
Perubahan (1 hari)
-1.07%
Perubahan (1 tahun)
-64.75%
Negara
TW
Perdagangan Lumosa Therapeutics Co., Ltd. (6535)

Kategori

Sejarah hasil dividen untuk Lumosa Therapeutics Co., Ltd. (6535)
Hasil dividen (TTM) bagi Lumosa Therapeutics Co., Ltd. (simbol saham: 6535) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Lumosa Therapeutics Co., Ltd. (6535) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
0.00%
US
0.00%
NL
2.48%
AU
0.00%
US
0.00%
CH